Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-23 5:16 pm Purchase | 2025-12-23 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 1,869,050 20.100% | 1,319,026 (+239.81%) | Filing History |
| 2025-12-23 4:49 pm Purchase | 2025-12-22 | 13D | Trinity Biotech plc TRIB | Perceptive Advisors LLC | 1,498,858,251 9.900% | 1,398,058,251 (+1386.96%) | Filing History |
| 2025-12-23 4:30 pm Purchase | 2025-12-18 | 13G | Tenax Therapeutics, Inc. TENX | Perceptive Advisors LLC | 439,142 7.000% | 439,142 (New Position) | Filing History |
| 2025-12-22 4:30 pm Purchase | 2025-12-18 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 550,024 13.900% | 550,024 (New Position) | Filing History |
| 2025-11-25 4:24 pm Sale | 2025-11-21 | 13D | Lyra Therapeutics, Inc. LYRA | Perceptive Advisors LLC | 0 0.000% | -98,301 (Position Closed) | Filing History |
| 2025-11-25 4:01 pm Purchase | 2025-11-18 | 13G | Invivyd, Inc. IVVD | Perceptive Advisors LLC | 21,785,166 7.900% | 21,785,166 (New Position) | Filing History |
| 2025-11-18 4:14 pm Sale | 2025-11-14 | 13D | Lyra Therapeutics, Inc. LYRA | Perceptive Advisors LLC | 98,301 5.500% | -40,584 (-29.22%) | Filing History |
| 2025-11-18 4:00 pm Purchase | 2025-11-11 | 13G | enGene Holdings Inc. ENGN | Perceptive Advisors LLC | 6,770,605 9.990% | 6,770,605 (New Position) | Filing History |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | Aldeyra Therapeutics, Inc. ALDX | Perceptive Advisors LLC | 5,222,311 8.700% | 1,170,680 (+28.89%) | Filing History |
| 2025-11-14 4:00 pm Sale | 2025-09-30 | 13G | Verona Pharma plc VRNA | Perceptive Advisors LLC | 0 0.000% | -5,507,591 (Position Closed) | Filing History |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | Inventiva S.A. IVA | Perceptive Advisors LLC | 7,300,666 4.990% | 1,745,111 (+31.41%) | Filing History |
| 2025-11-14 4:00 pm Sale | 2025-09-30 | 13G | KALA BIO, Inc. KALA | Perceptive Advisors LLC | 0 0.000% | -543,745 (Position Closed) | Filing History |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | Orchestra BioMed Holdings, Inc. OBIO | Perceptive Advisors LLC | 5,679,480 9.990% | 1,086,924 (+23.67%) | Filing History |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | Traws Pharma, Inc. TRAW | Perceptive Advisors LLC | 886,887 9.990% | 341,690 (+62.67%) | Filing History |
| 2025-11-14 4:00 pm Sale | 2025-09-30 | 13G | Artivion, Inc. AORT | Perceptive Advisors LLC | 2,020,000 4.300% | -363,978 (-15.27%) | Filing History |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Perceptive Advisors LLC | 8,952,365 8.200% | 1,078,017 (+13.69%) | Filing History |
| 2025-11-13 5:05 pm Sale | 2025-11-11 | 13D | Lyra Therapeutics, Inc. LYRA | Perceptive Advisors LLC | 138,885 7.800% | -45,875 (-24.83%) | Filing History |
| 2025-11-10 5:07 pm Purchase | 2025-11-06 | 13D | Lyra Therapeutics, Inc. LYRA | Perceptive Advisors LLC | 184,760 11.200% | 184,760 (New Position) | Filing History |
| 2025-11-03 4:09 pm Purchase | 2025-10-27 | 13G | X4 Pharmaceuticals, Inc. XFOR | Perceptive Advisors LLC | 6,064,680 7.600% | 6,064,680 (New Position) | Filing History |
| 2025-10-24 7:30 pm Purchase | 2025-10-23 | 13D | Trinity Biotech plc TRIB | Perceptive Advisors LLC | 100,800,000 22.500% | 83,640,000 (+487.41%) | Filing History |